Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2026-02-17 11:05 am Purchase | 2025-12-31 | 13G | TEVA PHARMACEUTICAL LTD INDS A TEVA | Migdal Insurance & Financial Holdings Ltd. | 61,689,363 5.370% | 61,689,363 (New Position) | Filing History |
| 2026-02-09 06:03 am Purchase | 2025-12-31 | 13G | TEVA PHARMACEUTICAL LTD INDS A TEVA | Harel Insurance Investments & Financial Services Ltd. | 72,325,555 6.300% | 14,207,333 (+24.45%) | Filing History |
| 2025-11-05 11:49 am Sale | 2025-09-30 | 13G | TEVA PHARMACEUTICAL LTD INDS A TEVA | FMR LLC | 24,641,361 2.100% | -33,494,255 (-57.61%) | Filing History |
| 2025-10-06 06:08 am Purchase | 2025-09-29 | 13G | TEVA PHARMACEUTICAL LTD INDS A TEVA | Harel Insurance Investments & Financial Services Ltd. | 58,118,222 5.100% | 58,118,222 (New Position) | Filing History |
| 2025-08-06 12:14 pm Sale | 2025-06-30 | 13G | TEVA PHARMACEUTICAL LTD INDS A TEVA | FMR LLC | 58,135,616 5.100% | -23,847,613 (-29.09%) | Filing History |
| 2025-07-22 09:25 am Purchase | 2025-07-14 | 13G | TEVA PHARMACEUTICAL LTD INDS A TEVA | Phoenix Financial Ltd. | 57,383,158 5.000% | 3,238,161 (+5.98%) | Filing History |
| 2025-07-17 11:57 am Purchase | 2025-07-16 | 13G | TEVA PHARMACEUTICAL LTD INDS A TEVA | MENORA MIVTACHIM HOLDINGS LTD. | 57,395,173 5.000% | 57,395,173 (New Position) | Filing History |
| 2025-02-12 09:22 am Purchase | 2024-12-31 | 13G | TEVA PHARMACEUTICAL LTD INDS A TEVA | FMR LLC | 81,983,229 7.200% | 19,242,467 (+30.67%) | Filing History |
| 2024-11-12 10:34 am Purchase | 2024-11-08 | 13G | TEVA PHARMACEUTICAL LTD INDS A TEVA | FMR LLC | 62,740,762 5.537% | 33,877,274 (+117.37%) | Filing History |
| 2024-04-09 10:26 am Sale | 2024-04-01 | 13G | TEVA PHARMACEUTICAL LTD INDS A TEVA | Phoenix Financial Ltd. | 54,144,997 4.830% | -6,377,181 (-10.54%) | Filing History |
| 2024-02-01 08:03 am Purchase | 2023-12-31 | 13G | TEVA PHARMACEUTICAL LTD INDS A TEVA | Phoenix Financial Ltd. | 60,522,178 5.400% | 60,522,178 (New Position) | Filing History |
| 2023-06-09 12:32 pm Sale | 2023-06-12 | 13G | TEVA PHARMACEUTICAL LTD INDS A TEVA | Capital Research Global Investors | 0 0.000% | -114,793,989 (Position Closed) | Filing History |
| 2023-02-13 3:32 pm Sale | 2023-02-14 | 13G | TEVA PHARMACEUTICAL LTD INDS A TEVA | Capital Research Global Investors | 114,793,989 10.300% | -17,556,761 (-13.27%) | Filing History |
| 2022-02-11 12:22 pm Purchase | 2022-02-14 | 13G | TEVA PHARMACEUTICAL LTD INDS A TEVA | Capital Research Global Investors | 132,350,750 12.000% | 2,210,503 (+1.70%) | Filing History |